These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 1324242)
1. Ethanol inhibits ligand-activated Ca2+ channels in human B lymphocytes. Brodie C; Domenico J; Mazer BD; Gelfand EW J Cell Physiol; 1992 Sep; 152(3):441-7. PubMed ID: 1324242 [TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B lymphoblastoid cells. Mazer B; Domenico J; Sawami H; Gelfand EW J Immunol; 1991 Mar; 146(6):1914-20. PubMed ID: 1848574 [TBL] [Abstract][Full Text] [Related]
3. Role for Ca2+ in expression of cell cycle regulated genes in PAF-stimulated cells. Mazer BD; Domenico J; Szepesi A; Lucas JJ; Gelfand EW J Lipid Mediat Cell Signal; 1994 Sep; 10(3):269-81. PubMed ID: 7812677 [TBL] [Abstract][Full Text] [Related]
4. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells. Page DM; DeFranco AL J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499 [TBL] [Abstract][Full Text] [Related]
5. Anti-IgM and anti-IgG modulate c-fos RNA levels differently in human B lymphocytes. Shu J; Benedict SH; Chan MA Cell Immunol; 1994 Dec; 159(2):170-83. PubMed ID: 7994752 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27Kip1 in splenic B cells activated by surface Ig cross-linking. Kobayashi K; Phuchareon J; Inada K; Tomita Y; Koizumi T; Hatano M; Miyatake S; Tokuhisa T J Immunol; 1997 Mar; 158(5):2050-6. PubMed ID: 9036948 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the B cell immune response: induction of competence and progression in a surface IgM-bearing subset. Chan MA; McGrath TH; Gelfand EW Cell Immunol; 1993 Feb; 146(2):300-12. PubMed ID: 8174172 [TBL] [Abstract][Full Text] [Related]
8. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. Klemsz MJ; Justement LB; Palmer E; Cambier JC J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345 [TBL] [Abstract][Full Text] [Related]
9. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921 [TBL] [Abstract][Full Text] [Related]
10. Activation and infection of B cells by Epstein-Barr virus. Role of calcium mobilization and of protein kinase C translocation. Dugas B; Delfraissy JF; Calenda A; Peuchmaur M; Wallon C; Rannou MT; Galanaud P J Immunol; 1988 Dec; 141(12):4344-51. PubMed ID: 2848895 [TBL] [Abstract][Full Text] [Related]
11. TNF-alpha inhibits anti-IgM-mediated apoptosis in Ramos cells. Park E; Kalunta CI; Nguyen TT; Wang CL; Chen FS; Lin CK; Kaptein JS; Lad PM Exp Cell Res; 1996 Jul; 226(1):1-10. PubMed ID: 8660933 [TBL] [Abstract][Full Text] [Related]
12. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition. Haggerty HG; Monroe JG Cell Immunol; 1994 Mar; 154(1):166-80. PubMed ID: 8118885 [TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line. Schulam PG; Kuruvilla A; Putcha G; Mangus L; Franklin-Johnson J; Shearer WT J Immunol; 1991 Mar; 146(5):1642-8. PubMed ID: 1847170 [TBL] [Abstract][Full Text] [Related]
14. Ethanol inhibits early events in T-lymphocyte activation. Brodie C; Domenico J; Gelfand EW Clin Immunol Immunopathol; 1994 Feb; 70(2):129-36. PubMed ID: 8299228 [TBL] [Abstract][Full Text] [Related]
15. Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes. Bastien Y; Toledano BJ; Mehio N; Cameron L; Lamoukhaid B; Renzi P; Hamid Q; Mazer BD J Immunol; 1999 May; 162(9):5498-505. PubMed ID: 10228030 [TBL] [Abstract][Full Text] [Related]
16. Characterization of B lymphocytes rescued from apoptosis by platelet-activating factor. Toledano BJ; Bastien Y; Noya F; Mazer B Cell Immunol; 1999 Jan; 191(1):60-8. PubMed ID: 9918687 [TBL] [Abstract][Full Text] [Related]
17. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies. Gruber MF; Bjorndahl JM; Nakamura S; Fu SM J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814 [TBL] [Abstract][Full Text] [Related]
18. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine. Tordai A; Franklin RA; Johnson C; Mazer BD; Clay KL; Gelfand EW J Immunol; 1994 Jan; 152(2):566-73. PubMed ID: 8283038 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line. Kuruvilla A; Putcha G; Poulos E; Shearer WT J Immunol; 1993 Jul; 151(2):637-48. PubMed ID: 8393037 [TBL] [Abstract][Full Text] [Related]
20. Increased plasma membrane permeability to Ca2+ in anti-Ig-stimulated B lymphocytes is dependent on activation of phosphoinositide hydrolysis. Ransom JT; Chen M; Sandoval VM; Pasternak JA; Digiusto D; Cambier JC J Immunol; 1988 May; 140(9):3150-5. PubMed ID: 2834453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]